Seventeen

Timor treatment via the intracancer injection of a biocompatible gel with radioactive particles

Total raised

€4.2M

€4,200,000

Funding rounds

Investors

distinct backers

Active since

2016-08

latest 2016-08

Funding by year

EUR raised per year

High confidence

Raise-next likelihood16

base rate 44% for Series A

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2016-09-01	Series A	€4.2M	Innogest Capital,Panakes Partners	View deal →

same sector or country